Bill

Bill > S4333


US S4333

US S4333
CLEAR Act Consistent Legal Evaluation And Regulation of Medical Products Act


summary

Introduced
05/26/2022
In Committee
05/26/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To deem certain products regulated by the Food and Drug Administration as drugs.

AI Summary

This bill, the Consistent Legal Evaluation And Regulation of Medical Products Act (CLEAR Act), deems certain products regulated by the Food and Drug Administration (FDA) as drugs rather than devices. Specifically, it categorizes contrast agents, radioactive drugs, over-the-counter (OTC) monograph drugs, and ophthalmic drug articles as drugs under the Federal Food, Drug, and Cosmetic Act. The bill applies this change to new and pending applications for these products, regardless of when the application was submitted, to ensure consistent regulation of these medical products as drugs rather than devices.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 05/26/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...